Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Intervalo de ano de publicação
1.
Braz J Biol ; 71(1): 57-63, 2011 02.
Artigo em Inglês | MEDLINE | ID: mdl-21437399

RESUMO

This study concerns the kinetics of bacterial degradation of two fractions (molecular mass) of dissolved organic matter (DOM) released by Microcystis aeruginosa. Barra Bonita Reservoir (SP, Brazil) conditions were simulated in the laboratory using the associated local bacterial community. The extent of degradation was quantified as the amount of organic carbon transferred from each DOM fraction (< 3 kDa and 3-30 kDa) to bacteria. The variation of bacteria morphotypes associated with the decomposition of each fraction was observed. To find the degradation rate constants (kT), the time profiles of the total, dissolved and particulate organic carbon concentrations were fitted to a first-order kinetic model. These rate constants were higher for the 3-30 kDa fraction than for the lighter fraction. Only in the latter fraction the formation of refractory dissolved organic carbon (DOCR) compounds could be detected and its rate of mass loss was low. The higher bacterial density was reached at 24 and 48 hours for small and higher fractions, respectively. In the first 48 hours of decomposition of both fractions, there was an early predominance of bacillus, succeeded by coccobacillus, vibrios and coccus, and from day 5 to 27, the bacterial density declined and there was greater evenness among the morphotypes. Both fractions of DOM were consumed rapidly, corroborating the hypothesis that DOM is readily available in the environment. This also suggests that the bacterial community in the inocula readily uses the labile part of the DOM, until this community is able to metabolise efficiently the remaining of DOM not degraded in the first moment. Given that M. aeruginosa blooms recur throughout the year in some eutrophic reservoirs, there is a constant supply of the same DOM which could maintain a consortium of bacterial morphotypes adapted to consuming this substrate.


Assuntos
Biodegradação Ambiental , Carbono/metabolismo , Água Doce/microbiologia , Microcystis/metabolismo , Compostos Orgânicos/metabolismo , Água Doce/química , Microcystis/crescimento & desenvolvimento , Compostos Orgânicos/química , Fatores de Tempo , Microbiologia da Água
2.
Braz J Med Biol Res ; 35(7): 819-22, 2002 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12131922

RESUMO

Topoisomerase inhibitors are agents with anticancer activity. 7"-O-Methyl-agathisflavone (I) and amentoflavone (II) are biflavonoids and were isolated from the Brazilian plants Ouratea hexasperma and O. semiserrata, respectively. These biflavonoids and the acetyl derivative of II (IIa) are inhibitors of human DNA topoisomerases I at 200 microM, as demonstrated by the relaxation assay of supercoiled DNA, and only agathisflavone (I) at 200 microM also inhibited DNA topoisomerases II-alpha, as observed by decatenation and relaxation assays. The biflavonoids showed concentration-dependent growth inhibitory activities on Ehrlich carcinoma cells in 45-h culture, assayed by a tetrazolium method, with IC50 = 24 +/- 1.4 microM for I, 26 +/- 1.1 microM for II and 10 +/- 0.7 microM for IIa. These biflavonoids were assayed against human K562 leukemia cells in 45-h culture, but only I showed 42% growth inhibitory activity at 90 microM. Our results suggest that biflavonoids are targets for DNA topoisomerases and their cytotoxicity is dependent on tumor cell type.


Assuntos
Antineoplásicos Fitogênicos/farmacologia , Inibidores Enzimáticos/farmacologia , Flavonoides/farmacologia , Inibidores da Topoisomerase I , Animais , Antineoplásicos Fitogênicos/isolamento & purificação , Brasil , Carcinoma de Ehrlich/tratamento farmacológico , Carcinoma de Ehrlich/enzimologia , Ensaios de Seleção de Medicamentos Antitumorais , Eletroforese em Gel de Ágar , Inibidores Enzimáticos/isolamento & purificação , Flavonoides/isolamento & purificação , Humanos , Células K562/efeitos dos fármacos , Leucemia/enzimologia
3.
Braz. j. med. biol. res ; 35(7): 819-822, July 2002. ilus
Artigo em Inglês | LILACS | ID: lil-316736

RESUMO

Topoisomerase inhibitors are agents with anticancer activity. 7"-O-Methyl-agathisflavone (I) and amentoflavone (II) are biflavonoids and were isolated from the Brazilian plants Ouratea hexasperma and O. semiserrata, respectively. These biflavonoids and the acetyl derivative of II (IIa) are inhibitors of human DNA topoisomerases I at 200 æM, as demonstrated by the relaxation assay of supercoiled DNA, and only agathisflavone (I) at 200 æM also inhibited DNA topoisomerases II-alpha, as observed by decatenation and relaxation assays. The biflavonoids showed concentration-dependent growth inhibitory activities on Ehrlich carcinoma cells in 45-h culture, assayed by a tetrazolium method, with IC50 = 24 ± 1.4 æM for I, 26 ± 1.1 æM for II and 10 ± 0.7 æM for IIa. These biflavonoids were assayed against human K562 leukemia cells in 45-h culture, but only I showed 42 percent growth inhibitory activity at 90 æM. Our results suggest that biflavonoids are targets for DNA topoisomerases and their cytotoxicity is dependent on tumor cell type


Assuntos
Humanos , Animais , Antineoplásicos Fitogênicos , DNA Topoisomerases Tipo I , Inibidores Enzimáticos , Flavonoides , Plantas , Antineoplásicos Fitogênicos , Brasil , Carcinoma de Ehrlich , Sobrevivência Celular , Eletroforese em Gel de Ágar , Inibidores Enzimáticos , Flavonoides , Células K562 , Leucemia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA